Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Physiol Regul Integr Comp Physiol ; 295(2): R404-16, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18550868

RESUMO

Repeated restraint stress (RRS; 3 h of restraint on 3 consecutive days) in rodents produces temporary hypophagia, but a long-term downregulation of body weight. The mild stress (MS) of an intraperitoneal injection of saline and housing in a novel room for 2 h also inhibits food intake and weight gain, but the effects are smaller than for RRS. Previous exposure to RRS exaggerates hypophagia, glucocorticoid release, and anxiety-type behavior caused by MS. Here we tested the involvement of brain stem corticotrophin-releasing factor receptors (CRFR) in mediating energetic and glucocorticoid responses to RRS or MS and in promoting stress hyperresponsiveness in RRS rats. Administration of 1.3 nmol alphahCRF(9-41), a nonspecific CRFR antagonist, exaggerated hypophagia and weight loss in both RRS and MS rats, whereas 0.26 nmol had no effect in RRS or MS rats. In contrast, 2 nmol of the nonspecific antagonist astressin had no effect on weight loss or hypersensitivity to subsequent MS in RRS rats, but blocked weight loss and inhibition of food intake caused by MS alone. MS rats infused with 3 nmol antisauvagine-30, a CRFR2 antagonist, did not lose weight in the 48 h after MS, but 0.3 nmol did not prevent weight loss in MS rats. These data suggest that inhibition of food intake and weight loss induced by RRS or by MS involve different pathways, with hindbrain CRFR mediating the effect of MS on body weight and food intake. Hindbrain CRFR do not appear to influence stress-induced corticosterone release in RRS rats.


Assuntos
Comportamento Animal/efeitos dos fármacos , Corticosterona/metabolismo , Hormônio Liberador da Corticotropina/administração & dosagem , Ingestão de Alimentos/efeitos dos fármacos , Quarto Ventrículo/efeitos dos fármacos , Fragmentos de Peptídeos/administração & dosagem , Receptores de Hormônio Liberador da Corticotropina/antagonistas & inibidores , Estresse Psicológico/prevenção & controle , Redução de Peso/efeitos dos fármacos , Animais , Hormônio Liberador da Corticotropina/farmacologia , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Quarto Ventrículo/metabolismo , Infusões Parenterais , Injeções Intraperitoneais , Masculino , Fragmentos de Peptídeos/farmacologia , Ratos , Ratos Sprague-Dawley , Receptores de Hormônio Liberador da Corticotropina/metabolismo , Restrição Física , Estresse Psicológico/etiologia , Estresse Psicológico/metabolismo , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...